All Boehringer Ingelheim inhalers are now available for $35 a month for patients with commercial insurance and for those who do not have insurance.* Please visit www.Spiriva.com/Asthma/Registration for more information.*Terms and conditions apply. At retail pharmacies. Government restrictions exclude people enrolled in federal government insurance programs from $35 solutions.

Get free, personalized support when you join the inhaleability HUB today! >>>

Spiriva-asthma-header

Breathe better for a full 24 hours with steroid-free SPIRIVA RESPIMAT

Female working out with Spiriva Respimat Inhalation Spray

Better breathing with SPIRIVA RESPIMAT
(tiotropium bromide) Inhalation Spray, 1.25 mcg

24 hour

Open airways for 24 hrs

SPIRIVA RESPIMAT opens asthma-constricted airways for a full 24 hours

Without additional inhaled steroids logo

Steroid-free

A steroid-free maintenance medication that's delivered in a soft mist

Reduce logo

Lower the risk

Proven* to reduce the risk of attacks in adults†

* These findings were published in a study by Kerstjens HAM, Casale TB, Bleecker ER, et al in The Lancet Respiratory Medicine journal in 2015.

† An asthma attack (exacerbation) was defined as an increase in asthma symptoms (shortness of breath, coughing, wheezing, or chest tightness), or trouble breathing for 2 or more consecutive days, requiring additional treatment.

Sign Up Now
Co-Pay card

Eligible patients pay as little as $35‡ for a 30-day prescription fill of SPIRIVA RESPIMAT

Don’t wait—get your Savings Card today.
Sign Up Now

‡Terms and Conditions Apply.

How to Use SPIRIVA RESPIMAT

Find out how SPIRIVA RESPIMAT works and see how to use it.

Learn More
Inhalation Spray device
Indications

SPIRIVA RESPIMAT, 2.5 mcg, is a long-term, once-daily, prescription medicine used to control symptoms of chronic obstructive pulmonary disease (COPD) by relaxing your airways and keeping them open. COPD includes chronic bronchitis and emphysema. SPIRIVA RESPIMAT also reduces the likelihood of COPD flare-ups (COPD exacerbations).

SPIRIVA RESPIMAT, 1.25 mcg, is a long-term, once-daily, prescription maintenance treatment of asthma for people 6 years and older.

SPIRIVA RESPIMAT is not a treatment for sudden symptoms of asthma or COPD.

Important Safety Information

Do not use SPIRIVA RESPIMAT if you are allergic to tiotropium, ipratropium, atropine or similar drugs, or any ingredient in these medicines.

SPIRIVA RESPIMAT is not a rescue medicine and should not be used for treating sudden breathing problems. Your doctor may give you other medicine to use for sudden breathing problems.

SPIRIVA RESPIMAT can cause allergic reactions. Symptoms can include raised red patches on your skin (hives), itching, rash and/or swelling of the lips, tongue, or throat that may cause difficulty in breathing or swallowing. If you have any of these symptoms, stop taking the medicine and get immediate medical care.

SPIRIVA RESPIMAT can cause your breathing to suddenly get worse (bronchospasm). If this happens, use your rescue inhaler, stop taking SPIRIVA RESPIMAT, and call your doctor right away or seek emergency medical care.

SPIRIVA RESPIMAT can increase the pressure in your eyes (acute narrow-angle glaucoma), which can cause the following symptoms: eye pain, blurred vision, seeing halos or colored images along with red eyes. If you have any of these symptoms, stop taking your medicine and call your doctor right away.

Dizziness and blurred vision may occur with SPIRIVA RESPIMAT. If you experience these symptoms, use caution when engaging in activities such as driving a car, or operating appliances or other machines.

SPIRIVA RESPIMAT can cause new or worsened urinary retention. Symptoms of blockage in your bladder and/or enlarged prostate may include difficulty passing urine and/or painful urination. If you have any of these symptoms, stop taking your medicine and call your doctor right away.

The most common side effects reported with SPIRIVA RESPIMAT in patients with COPD include sore throat, cough, dry mouth, and sinus infection.

The most common side effects with SPIRIVA RESPIMAT in adult patients with asthma were sore throat, headache, bronchitis, and sinus infection. The side effect profile for adolescent and pediatric patients was comparable to that observed in adult patients with asthma.

Do not spray SPIRIVA RESPIMAT into your eyes, as this may cause blurring of vision and pupil dilation.

Tell your doctor all the medicines you take, including eye drops. Ask your doctor if you are taking any anticholinergic medicines because taking them together with SPIRIVA RESPIMAT can increase side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

CL-SVR-0046 2.15.2017

Please see full Prescribing Information, including Instructions for Use, for SPIRIVA RESPIMAT.